Streetbeat News

Earnings

GOOG

TSLA

USO

Global markets experienced declines with U.S. stock markets closing in the red. Alphabet (GOOG) and Tesla (TSLA) reported positive Q2 revenues. The U.S. Fifth District’s composite manufacturing index fell, and existing home sales decreased. Crude oil prices hit a six-week low but slightly rebounded. Asian and European markets also saw declines.

Portfolio Pulse from Akanksha Bakshi

July 24, 2024 | 10:46 am

NVDA

TXN

Texas Instruments (NASDAQ:TXN) shares surged in pre-market trading after reporting Q2 earnings that exceeded expectations. The company reported earnings of $1.22 per share, surpassing the consensus estimate of $1.17. Quarterly sales were in line with estimates at $3.82 billion. The semiconductor sector, including Nvidia (NASDAQ:NVDA), has been performing well, driven by interest in AI.

Portfolio Pulse from Benzinga Neuro

July 24, 2024 | 10:45 am

TNL

Travel + Leisure reported a 13% year-over-year increase in Q2 tours, with new owner tours up by 22%.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:44 am

BSX

Boston Scientific estimates Q3 2024 net sales growth of approximately 13%-14% on a reported and organic basis, with adjusted EPS of $0.57-$0.59 versus consensus of $0.57.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:42 am

PERF

Perfect (NYSE:PERF) reported Q2 2024 earnings per share of $0.01, meeting analyst expectations. However, the company's sales of $13.900 million missed the $14.842 million estimate by 6.35%, despite a 9.45% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:40 am

T

AT&T shares are trading higher following Q2 earnings.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:40 am

BSX

Boston Scientific has updated its 2024 adjusted EPS guidance to a range of $2.38-$2.42, up from the prior guidance of $2.29-$2.34 and above the consensus estimate of $2.33.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:40 am

TECK

Teck Resources shares are trading lower following mixed Q2 earnings results.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:39 am

BSX

Boston Scientific has updated its 2024 net sales growth estimates to 13.5%-14.5% on a reported basis and 13%-14% on an organic basis, which is an increase from the prior guidance of 11%-13% and 10%-12%, respectively.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:38 am

ENPH

Enphase Energy shares are trading higher despite reporting worse-than-expected Q2 earnings and guidance with a midpoint below estimates.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:37 am